애널컨센 30
구강점막염
당분간은 마이너스가 커질듯
매출도 없음
현금 18m
오퍼링은 반드시 일어날듯
Monopar Therapeutics Inc.
Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar is building a drug development pipeline through the licens
www.monopartx.com
728x90
'---매수대상--- > 미국 스몰캡 주당 10불 이하' 카테고리의 다른 글
| BXRX 1.6$ (3) | 2021.03.01 |
|---|---|
| KALA 8.73 (0) | 2021.02.28 |
| ONDAS 12.45 (0) | 2021.02.28 |
| NVCN 1.95$ (0) | 2021.02.27 |
| ONCY 3.5 210219 (0) | 2021.02.21 |
댓글